Archive
The archive is under construction. If you are in search of an article that has not yet been uploaded, please do not hesitate to contact us.
Articles since March 2023 are available on Frontiers website. For articles since 2009, click here.
Volume 34, 1990, No. 5
ISSN 1336-2305 (online)
Content
- COMPARISON OF THE ACTION OF IONIZING RADIATION AND UV-LIGHT ON LAMBDA PHAGE. INFLUENCE ON PHAGE ADSORPTION, DNA INJECTION, REPLICATION, AND DNA REPAIR. / p. 401
- DETERMINATION OF SEROTYPES OF RED CLOVER NECROTIC MOSAIC VIRUS B Y ENZYME-LINKED IMMUNOSORBENT ASSAY. / p. 410
- LYMPHOKINE RELEASE A S MEASUREMENT OF ANTI-MOUSE HEPATITIS VIRUS TYPE 3 (MHV3) CELLULAR REACTIONS I N VARIOUS MOUSE LINES EXHIBITING DIFFERENTIAL SUSCEPTIBILITIES TO MHV3-INDUCED PARALYSIS. / p. 423
- PRESENCE OF ANTIBODY REACTIVE WITH SYNTHETIC PEPTIDE DERIVED FROM L2 OPEN READING FRAME OF HUMAN PAPILLOMAVIRUS TYPES 6b A N D 11 IN HUMAN SERA. / p. 433
- IDENTIFICATION OF AN INFECTIOUS LARYNGOTRACHEITIS VIRUS EQUIVALENT TO THE HERPES SIMPLEX VIRUS TYPE 2 MAJOR DNA BINDING PROTEIN (ICP8). / p. 443
- INFLUENZA VIRUS DETECTION IN CLINICAL SPECIMENS. / p. 449
- TRANSIENT INCREASEO F HBsAgLEVELS FOLLOWING HUMAN IFN ALPHA TREATMENT SIGNALISES THE PATIENT'S RESPONSE IN CHRONIC ACTIVE HEPATITIS B. / p. 457
- TRANSIENT INCREASE OF HBsAg LEVELS FOLLOWING HUMAN IFN ALPHA TREATMENT SIGNALISED THE PATIENT'S RESPONSE IN CHRONIC ACTIVE HEPATITIS B. / p. 457
- IMMUNOLOGICAL MARKERS IN PATIENTS WITH DIFFERENT FORMS OF VIRAL HEPATITIS B TREATED B Y "CONVENTIONAL" THERAPY OR WITH HuIFN ALPHA. / p. 467
- LATENCY COMPETENCE OF HERPES SIMPLEX VIRUS STRAINS ANG, ANGpath AND ITS gC AND gE MINUS MUTANS. / p. 477
- INTRACELLULAR LOCALIZATION OF RECOMBINANT VACCINA VIRUS PRODUCED HIV ANTIGENS AND THEIR USE FOR CONFIRMATION OF HIV SEROPOSITIVITY. / p. 487
- RADIOIMMUNOASSAY AND OLIGONUCLEOTIDE MAPPING OF A/HswlNl INFLUENZA VIRUSES ISOLATED FROM HUMANS AND ANIMALS. / p. 493
- A SIMPLE AND EFFECTIVE METHOD OF PREPARING ROTAVIRUS ANTIGEN IN PREPARATIVE QUANTITIES. / p. 494
- ARE ANIMAL RETROVIRUSES POTENTIAL CANDIDATES FOR AN AIDS VACCINE?. / p. 495